Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-011363
Filing Date
2018-08-17
Accepted
2018-08-17 16:47:39
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_conversionlabsinc.htm 10-Q 488538
2 CERTIFICATION f10q0618ex31-1_conversion.htm EX-31.1 9920
3 CERTIFICATION f10q0618ex31-2_conversion.htm EX-31.2 10010
4 CERTIFICATION f10q0618ex32-1_conversion.htm EX-32.1 4575
5 CERTIFICATION f10q0618ex32-2_conversion.htm EX-32.2 4494
  Complete submission text file 0001213900-18-011363.txt   4798548

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cvlb-20180630.xml EX-101.INS 798738
7 XBRL SCHEMA FILE cvlb-20180630.xsd EX-101.SCH 49370
8 XBRL CALCULATION FILE cvlb-20180630_cal.xml EX-101.CAL 48123
9 XBRL DEFINITION FILE cvlb-20180630_def.xml EX-101.DEF 247945
10 XBRL LABEL FILE cvlb-20180630_lab.xml EX-101.LAB 530442
11 XBRL PRESENTATION FILE cvlb-20180630_pre.xml EX-101.PRE 373325
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
CONVERSION LABS, INC. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55857 | Film No.: 181026268
SIC: 2833 Medicinal Chemicals & Botanical Products